POZ - Latino Hub : Treatment News : ARV Treatment Protects Against Malaria in Ugandan Study - by Tim Horn

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

July 21, 2009

ARV Treatment Protects Against Malaria in Ugandan Study

by Tim Horn

Using antiretroviral (ARV) therapy to restore the immune system may substantially reduce the risk of malaria in countries where both HIV and malaria are endemic, according to new data presented Tuesday, July 21, at the Fifth International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town.

HIV and malaria can breed severe combined epidemics. It has been well documented that malaria, a protozoal infection transmitted via the bites of infected mosquitoes, boosts a person’s HIV viral load. Similarly, people living with HIV appear to be more vulnerable to the parasite Plasmodium and to severe disease.

Malaria is endemic throughout Africa and southern Asia, regions with high HIV rates. Yet little is known regarding the effects of ARV therapy on the incidence of malaria and its risk factors.

To explore this important question, Ronald Kasirye, MD, of the UVRI Uganda Research Unit on AIDS in Entebbe and his colleagues analyzed data involving 1,020 people living with HIV enrolled at the Entebbe research unit participating in the large Development of Antiretroviral Therapy for Africa (DART) trial.

Kasirye’s group tracked DART participants for four years after they began therapy, evaluating any fever-inducing illness for possible malaria as well as for other possible infectious illnesses.

In total, 524 (51 percent) patients experienced at least one episode of malaria. The incidence—new infection rate—of malaria fell with each year of ARV therapy use, from 59 percent after one year of treatment, to 48 percent after two years, 26 percent after three years and 16 percent beyond three years.

Statistical analyses conducted by Kasirye’s group determined that a lower CD4 count—notably fewer than 10 cells per cubic millimeter—when starting ARV therapy independently raised the risk of a new malaria diagnosis.

For Kasirye, the implications of this study are clear. The indirect effect of ARV therapy in combination with other control measures could help reduce disease and death caused by HIV infection and malaria.

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.